This sunscreen uses special fat-based nanoparticles and a plant-derived compound to help the sunscreen stay stable and not get absorbed into the body.
Scientific Claim
The NLC-TRF sunscreen formulation contains tocotrienol-rich fraction (TRF) and nanostructured lipid carriers (NLCs) designed to improve UV filter stability and reduce systemic absorption.
Original Statement
“The study aimed to investigate the safety profile... of sunscreen (NLC-TRF sunscreen) produced from nanostructured lipid carriers (NLCs) and tocotrienol-rich fraction (TRF).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim merely reports the ingredients explicitly named in the abstract. No causal or outcome claims are made. The language is factual and appropriate.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1aWhether inclusion of TRF and NLCs in sunscreen reduces systemic absorption of UV filters compared to conventional formulations.
Whether inclusion of TRF and NLCs in sunscreen reduces systemic absorption of UV filters compared to conventional formulations.
What This Would Prove
Whether inclusion of TRF and NLCs in sunscreen reduces systemic absorption of UV filters compared to conventional formulations.
Ideal Study Design
A double-blind RCT with 40 healthy adults applying NLC-TRF sunscreen vs. identical sunscreen without TRF/NLCs, measuring plasma concentrations of DHHB and EHT via LC-MS/MS at 0, 2, 4, 8, and 24 hours post-application.
Limitation: Does not assess long-term accumulation or clinical consequences of absorption.
In Vivo Animal StudyLevel 4Whether TRF and NLCs reduce dermal penetration and systemic bioavailability of UV filters compared to non-NLC formulations.
Whether TRF and NLCs reduce dermal penetration and systemic bioavailability of UV filters compared to non-NLC formulations.
What This Would Prove
Whether TRF and NLCs reduce dermal penetration and systemic bioavailability of UV filters compared to non-NLC formulations.
Ideal Study Design
A study using 24 hairless rats applying NLC-TRF or control sunscreen, with skin biopsies and blood sampling at 2, 4, and 8 hours to quantify UV filter concentrations in epidermis, dermis, and plasma.
Limitation: Rat skin permeability differs from human skin; cannot directly extrapolate.
In Vitro StudyLevel 4In EvidenceWhether NLCs and TRF alter the permeation profile of UV filters through artificial membranes or skin models.
Whether NLCs and TRF alter the permeation profile of UV filters through artificial membranes or skin models.
What This Would Prove
Whether NLCs and TRF alter the permeation profile of UV filters through artificial membranes or skin models.
Ideal Study Design
The current study design — using Franz diffusion cells with human skin models to compare permeation of UV filters with and without NLCs/TRF — is the standard method for preliminary penetration assessment.
Limitation: Does not reflect metabolic degradation, immune response, or real skin variability.
Evidence from Studies
Supporting (1)
In vitro safety evaluation of sunscreen formulation from nanostructured lipid carriers using human cells and skin model.
This study tested the exact sunscreen mentioned in the claim and found that it stays effective longer in the sun and doesn’t get absorbed into the body much, which is exactly what the claim says.